Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Institute of Chemical Biology and Fundamental Medicine · Siberian Branch of the Russian Academy of Sciences
Abstract
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung architecture disruption and respiratory failure. The development of pulmonary fibrosis is mostly the result of previous acute lung inflammation, caused by a wide variety of etiological factors, not resolved over time and causing the deposition of fibrotic tissue in the lungs. Despite a long history of study and good coverage of the problem in the scientific literature, the effective therapeutic approaches for pulmonary fibrosis treatment are currently lacking. Thus, the study of the molecular mechanisms underlying the transition from acute lung inflammation to pulmonary fibrosis, and the search for new molecular markers and…
Citation impact
- FWCI
- 32.49
- Percentile
- 100%
- References
- 458
Authors
3- IAInnokenty A. Savin
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
- MAMarina A. ZenkovaCorresponding
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
- AVAleksandra V. Sen’kova
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
Topics & keywords
- Pulmonary fibrosis
- Lung
- Fibrosis
- Medicine
- Inflammation
- Idiopathic pulmonary fibrosis
- Pathology
- Pathogenesis
- Good health and well-being